Did you know you can now get UNLIMITED CE Hours for only $74.95?
Click Here to learn more.

CEU Course Description

Research indicates that substance use disorders are highly prevalent among inmate populations. Research also indicates that the inmate patient population is on the rise. Therefore, health care professionals should be familiar with recommendations related to the medical management of withdrawal to effectively care for patients in need. With that in mind, this course reviews the Federal Bureau of Prisons' (BOP) evidence-based resource guide, Medically Supervised Withdrawal for Inmates with Substance Use Disorders, which provides recommendations for the effective medical management of withdrawal for inmates with substance use disorders.

Author: This document was previously issued in 2014 as the Federal Bureau of Prisons' Clinical Guidance for Detoxification of Chemically Dependent Inmates. The 2014 BOP Clinical Guidance for Detoxification of Chemically Dependent Inmates was revised from a previous version of the guidance to be in line with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). This is the updated document published in February 2020. 

Recommended Citation: Federal Bureau of Prisons. Federal Bureau of Prisons Clinical Guidance. Medically Supervised Withdrawal for Inmates with Substance Use Disorders. February 2020. 

References / Contributions by: 

1. American Psychiatric Association. Practice Guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder. Washington, DC: American Psychiatric Association; 2018. Available at: https://psychiatryonline.org/doi/pdf/10.1176/appi.books.9781615371969 
2. Becker WC, Starrels JL. Prescription drug misuse: Epidemiology, prevention, identification, and management. In: UpToDate, Saxon AJ (Ed). Last updated August 13, 2019. Available at: https://www.uptodate.com/contents/prescription-drug-misuse-epidemiology-prevention-identification-andmanagement 
3. Park TW. Benzodiazepine use disorder: Epidemiology, pathogenesis, clinical manifestations, course, and diagnosis. In: UpToDate, Saitz R (Ed). Last updated September 26, 2017. 
4. U.S. Department of Justice, Bureau of Justice Statistics [homepage on the internet]. Available at: http://www.bjs.gov/ 

Retrieved: https://www.bop.gov/resources/pdfs/medically_supervised_withdrawal_cg.pdf 

CEU Course Objectives 

1. Recognize concepts central to treating/managing withdrawal.
2. Identify concepts specific to alcohol withdrawal and the treatment of alcohol withdrawal.
3. Examine benzodiazepine withdrawal and the treatment of benzodiazepine withdrawal.
4. Evaluate opioid withdrawal and the treatment of opioid withdrawal.
5. Recall concepts related to the use of barbiturates, cocaine/stimulants, and inhalants.

CE Outline with Main Points:

1. Purpose
2. Introduction
3. General Considerations in Treating Withdrawl
4. Management of Inmates for Treatment of Withdrawl
5. Placement of Inmates for Treatment of Withdrawl
6. Overview of Withdrawl Management
7. Alcohol Withdrawl
8. Benzodiazepine Withdrawl
9. Barbiturate Withdrawl
10. Opioid Withdrawl
11. Cocaine/Stimulants
12. Inhalants
13. Definitions
14. References
15. Appendix

ACE credit is not offered for this course. A list of courses offering ACE credit can be found here.

Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degrees of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.

*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at support@quantumunitsed.com.

Added On: 02/01/2020